BCL2L1 and colorectal cancer: Treatment with AZ’1569 resulted in acute increases in the proapoptotic protein BIM, which may “prime” cells for death, but was insufficient to cause apoptosis in five of seven KRASG12CMT colorectal cancer models due to the presence of inhibitory antiapoptotic proteins, such as Bcl-xL.